EARNED WEALTH ADVISORS, LLC
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 1905663
WALNUT CREEK, CA
Position in PLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,521
+$3,991 QoQ
Shares Held
25,975
-0.3% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#44
of 101 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EARNED WEALTH ADVISORS, LLC holds $753,363 across 3 Biotechnology names. PLX ranks #2 (8.0% of the industry book) .
All Filings in PLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,521 | 25,975 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,530 | 26,051 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $46,755 | 25,975 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $57,664 | 25,975 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $38,444 | 25,976 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $66,498 | 25,976 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $48,834 | 25,976 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $26,495 | 25,976 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $31,347 | 26,793 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $33,085 | 26,258 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $46,235 | 25,975 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $43,116 | 25,974 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $51,948 | 25,974 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $54,545 | 25,974 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $35,584 | 25,974 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $27,012 | 25,974 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $28,311 | 25,974 | Shares | Sole | 2022-07-26 | |
| No filing history on record for this holder in this stock. | ||||||